| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |